Ocean Grown Ventures (OGV) is a California-based holding and operating company that is committed to advancing the field of medical cannabis in the United States. Founded in 2017, OGV's primary focus is on developing high-quality products and fostering partnerships to drive scientific innovation in the medical cannabis sector.
The company has set its sights on Israel, recognizing the country's reputation for pioneering advancements in agriculture, technology, life sciences, and software. Israeli scientists are leading the charge in the cannabis industry, benefiting from the ability to conduct clinical trials and research studies with government approval. This advantage stems from Israel's more permissive regulatory environment, in stark contrast to the restrictions on cannabis research in the United States due to federal regulations. OGV's strategic partnerships, such as the collaboration with Panaxia Pharmaceutical Industries, underscore its commitment to introducing groundbreaking products to the market. One of the notable achievements resulting from this partnership is Tikva by Panaxia Pharmaceuticals. By leveraging its connections in Israel, OGV is at the forefront of importing innovative technologies and products into the US market. The company is actively forging new relationships and partnerships with key industry players in the US and beyond.There is no investment information
No recent news or press coverage available for Ocean Grown Ventures.